Lazard Capital Upgrades Edwards Lifesciences (EW) to Buy
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $90.81 -0.86%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Lazard Capital upgraded shares of Edwards Lifesciences (NYSE: EW) to a Buy rating from its previous rating of Neutral.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $69.02 yesterday.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $69.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
